🔴 Harrow Health is trading 6.1% down on October 30, 2026 with no identified catalyst

Harrow Health is trading at $28.37, down 6.09%, with no specific catalyst established.

• No fresh Harrow Health announcement or analyst action was found for October 30; the next earnings report is scheduled for November 9.
• Healthcare gained 2.32%, running counter to the stock’s decline, so sector strength does not explain the move.
• The earlier pre-market gain noted in the supplied alert context does not explain the subsequent drop; trading volume information was unavailable.